| Company Name: |
Labnetwork lnc. |
| Tel: |
+86-27-50766799 +86-18062016861 |
| Email: |
contact@labnetwork.com |
|
| | N-tert-Butoxycarbonyl-4-chloro-2-trifluoroacetylaniline Basic information |
| Product Name: | N-tert-Butoxycarbonyl-4-chloro-2-trifluoroacetylaniline | | Synonyms: | N-tert-Butoxycarbonyl-4-chloro-2-trifluoroacetylaniline;[4-Chloro-2-(2,2,2-trifluoro-acetyl)-phenyl]-carbamic acid tert-butyl ester;tert-Butyl N-[4-chloro-2-(trifluoroacetyl)phenyl]carbamate;Carbamic acid, N-[4-chloro-2-(2,2,2-trifluoroacetyl)phenyl]-, 1,1-dimethylethyl ester | | CAS: | 201218-07-7 | | MF: | C13H13ClF3NO3 | | MW: | 323.7 | | EINECS: | | | Product Categories: | | | Mol File: | 201218-07-7.mol |  |
| | N-tert-Butoxycarbonyl-4-chloro-2-trifluoroacetylaniline Chemical Properties |
| Boiling point | 326.1±42.0 °C(Predicted) | | density | 1.358±0.06 g/cm3(Predicted) | | pka | 11.90±0.70(Predicted) |
| | N-tert-Butoxycarbonyl-4-chloro-2-trifluoroacetylaniline Usage And Synthesis |
| Uses | N-tert-Butoxycarbonyl-4-chloro-2-trifluoroacetylaniline is an intermediate in the synthesis of rac Efavirenz-d5 (E425003), a labelled Efavirenz (E42500), a nonnucleoside HIV-1 reverse transcriptase inhibitor. |
| | N-tert-Butoxycarbonyl-4-chloro-2-trifluoroacetylaniline Preparation Products And Raw materials |
|